The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies

INTRODUCTION: There is a dramatic increase in the worldwide incidence of obesity, diabetes mellitus type 2, and other cardiovascular risk factors, summarized previously under the term "metabolic syndrome". Although preventive lifestyle modifications are effective, they are hard to implemen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pfeiffer, Michael (VerfasserIn) , Bauer, Rüdiger von (VerfasserIn) , Nawroth, Peter Paul (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 March 2011
In: Langenbeck's archives of surgery
Year: 2011, Jahrgang: 396, Heft: 7, Pages: 941-947
ISSN:1435-2451
DOI:10.1007/s00423-011-0781-z
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00423-011-0781-z
Volltext
Verfasserangaben:Michael Pfeiffer, Rüdiger von Bauer, Peter P. Nawroth

MARC

LEADER 00000caa a2200000 c 4500
001 1826701508
003 DE-627
005 20230710100132.0
007 cr uuu---uuuuu
008 221209s2011 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00423-011-0781-z  |2 doi 
035 |a (DE-627)1826701508 
035 |a (DE-599)KXP1826701508 
035 |a (OCoLC)1389740670 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfeiffer, Michael  |e VerfasserIn  |0 (DE-588)1275132685  |0 (DE-627)1826703535  |4 aut 
245 1 4 |a The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies  |c Michael Pfeiffer, Rüdiger von Bauer, Peter P. Nawroth 
264 1 |c 30 March 2011 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.12.2022 
520 |a INTRODUCTION: There is a dramatic increase in the worldwide incidence of obesity, diabetes mellitus type 2, and other cardiovascular risk factors, summarized previously under the term "metabolic syndrome". Although preventive lifestyle modifications are effective, they are hard to implement and are therefore associated with a high number needed to treat. In most cases, intervention studies with hard endpoints such as myocardial infarction, stroke, or death are missing. - RESULTS: For example, the Da Qing study proved the efficacy of lifestyle modification with respect to manifestation of diabetes, but failed to show clear benefits regarding cardiovascular mortality. Several studies raised doubt, whether the concept of optimally reducing glucose is the optimal treatment for improving cardiovascular endpoints. Moreover other studies, such as Steno-2, showed an impressive effect of a multimodal therapy on hard endpoints. - CONCLUSIONS: In the future, the focus on new strategies for individualized therapies will increase. Additionally, approaches targeting novel molecular pathways are on the horizon, since plasma levels of posttranslationally modified proteins such as HbA1c are strong cardiovascular risk predictors despite normal glucose levels. For the clinician, it now becomes obvious that epidemiologically proven associations do not necessarily reflect causality. Studies addressing defined clinical endpoints, such as micro- and macrovascular morbidity and mortality are needed, as well as basic research, investigating other pathophysiological mechanisms, e.g., reactive metabolites and the digestive tract. The unexplained reduction in diabetes and its complications by bariatric surgery will give further insight not only into new therapeutic approaches, but also into mechanisms yet to be discovered. 
650 4 |a Aged 
650 4 |a Blood Glucose 
650 4 |a Body Mass Index 
650 4 |a Cardiovascular Diseases 
650 4 |a Case-Control Studies 
650 4 |a Combined Modality Therapy 
650 4 |a Diabetes Mellitus, Type 2 
650 4 |a Female 
650 4 |a Germany 
650 4 |a Humans 
650 4 |a Incidence 
650 4 |a Life Style 
650 4 |a Male 
650 4 |a Metabolic Syndrome 
650 4 |a Middle Aged 
650 4 |a Obesity 
650 4 |a Primary Prevention 
650 4 |a Risk Assessment 
650 4 |a Risk Reduction Behavior 
650 4 |a Severity of Illness Index 
650 4 |a Survival Analysis 
700 1 |a Bauer, Rüdiger von  |e VerfasserIn  |0 (DE-588)1071417703  |0 (DE-627)825831482  |0 (DE-576)433070986  |4 aut 
700 1 |a Nawroth, Peter Paul  |d 1954-  |e VerfasserIn  |0 (DE-588)1020504897  |0 (DE-627)69123941X  |0 (DE-576)360517692  |4 aut 
773 0 8 |i Enthalten in  |t Langenbeck's archives of surgery  |d Berlin : Springer, 1998  |g 396(2011), 7, Seite 941-947  |h Online-Ressource  |w (DE-627)253770440  |w (DE-600)1459390-7  |w (DE-576)072578564  |x 1435-2451  |7 nnas  |a The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies 
773 1 8 |g volume:396  |g year:2011  |g number:7  |g pages:941-947  |g extent:7  |a The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies 
856 4 0 |u https://doi.org/10.1007/s00423-011-0781-z  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221209 
993 |a Article 
994 |a 2011 
998 |g 1020504897  |a Nawroth, Peter Paul  |m 1020504897:Nawroth, Peter Paul  |d 910000  |d 910100  |e 910000PN1020504897  |e 910100PN1020504897  |k 0/910000/  |k 1/910000/910100/ 
998 |g 1071417703  |a Bauer, Rüdiger von  |m 1071417703:Bauer, Rüdiger von  |d 910000  |d 910100  |e 910000PB1071417703  |e 910100PB1071417703  |k 0/910000/  |k 1/910000/910100/ 
999 |a KXP-PPN1826701508  |e 4228695825 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Michael","display":"Pfeiffer, Michael","role":"aut","family":"Pfeiffer"},{"role":"aut","display":"Bauer, Rüdiger von","family":"Bauer","given":"Rüdiger von"},{"display":"Nawroth, Peter Paul","role":"aut","family":"Nawroth","given":"Peter Paul"}],"title":[{"title_sort":"new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies","title":"The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies"}],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"30 March 2011"}],"name":{"displayForm":["Michael Pfeiffer, Rüdiger von Bauer, Peter P. Nawroth"]},"id":{"doi":["10.1007/s00423-011-0781-z"],"eki":["1826701508"]},"recId":"1826701508","language":["eng"],"physDesc":[{"extent":"7 S."}],"note":["Gesehen am 09.12.2022"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"pubHistory":["Volume 383, issue 1 (March 1998)-"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 24.03.25","Teils ungezählte Beil.: Supplement"],"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1998-","dateIssuedKey":"1998","publisher":"Springer"}],"corporate":[{"role":"isb","display":"Deutsche Gesellschaft für Chirurgie"}],"title":[{"title":"Langenbeck's archives of surgery","title_sort":"Langenbeck's archives of surgery","subtitle":"continues Langenbecks Archiv für Chirurgie : organ of the congresses of the German Society of Surgery : official journal of the German Association of Endocrine Surgeons, affiliated to the German Society of Surgery"}],"recId":"253770440","language":["eng"],"part":{"issue":"7","pages":"941-947","volume":"396","extent":"7","year":"2011","text":"396(2011), 7, Seite 941-947"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studiesLangenbeck's archives of surgery","id":{"zdb":["1459390-7"],"issn":["1435-2451"],"eki":["253770440"]}}]} 
SRT |a PFEIFFERMINEWPUZZLEA3020